Curated Science

Prescribing Infomation can be found through the links in the Product Cards at the bottom of the page

SPARTA study | Toujeo® (insulin glargine 300 units/mL)

Video: BRIGHT study | Toujeo® (insulin glargine 300 units/mL)

InRange Study | Toujeo® (Insulin Glargine 300 units/mL)

Biosimilar Head to Head Studies – vs originator Lispro rapid acting insulin

T1 Evidence in Children | Toujeo® (insulin glargine 300 units/mL)

T1 Edition Junior Study | Toujeo® (insulin glargine 300 units/mL)

ORION Observational Study | Toujeo® (insulin glargine 300 units/mL)

T1DM - Meta-Analysis | Toujeo® (insulin glargine 300 units/mL)

Biosimilar Head to Head Studies – vs originator Aspart rapid acting insulin

T1 Evidence in Adults | Toujeo® (Insulin Glargine 300 units/mL)
SEE EVERYTHING

Diabetes Products

ADMELOG
insulin lispro

Prescribing Information GB
GB ONLY CONTENT

MAT-GB-2105789 (v6.0)
Date of preparation: February 2023

LANTUS
insulin glargine

Prescribing Information GB
Prescribing Information NI

MAT-XU-2201444 (v3.0)
Date of preparation: January 2023

TOUJEO
insulin glargine

Prescribing Information UK

MAT-GB-2105435 (v6.0)
Date of preparation: February 2023

TRURAPI
insulin aspart

Prescribing Information GB
GB ONLY CONTENT

MAT-XU-2205461 (v5.0)
Date of preparation: March 2023

Get in touch with the Diabetes Team

MAT-XU-2201545 (v3.0)
Date of Preparation: February 2023

MAT-GB-2200621 (v5.0)
Date of preparation: March 2023